Article
The role of genetic variability in drug metabolism pathways in breast cancer prognosis.
Pharmacogenomics - 1 Jun 2006
Choi Ji-Yeob, Nowell Susan A, Blanco Javier G, Ambrosone Christine B
Abstract excerpt
Among patients receiving adjuvant therapy for breast cancer, there is variability in treatment outcomes, and it is unclear which patients will receive the most benefit from treatment and which will have better disease-free survival. To date, most studies of breast cancer prognosis have focused on tumor characteristics, but it is likely that pharmacogenetics, genetic variability in the metabolism of therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.